ValuEngine upgraded shares of Onconova Therapeutics (NASDAQ:ONTX) from a hold rating to a buy rating in a report published on Tuesday, ValuEngine reports.. Several other brokerages also recently commented on ONTX. Noble Financial reissued a buy rating and set a $1.30 target price on shares of Onconova Therapeutics in a research note on Friday, December 27th. The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp ... The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona Therapeutics Onconova Therapeutics Inc Stock (ONTX): Technical ... ONTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average. ONTX stock price (quote) - Onconova Therapeutics Close price at the end of the last trading day (Friday, 27th Dec 2019) of the ONTX stock was $0.41. This is 32.27% more than the trading day before Thursday, 26th Dec 2019. During the day the stock fluctuated 37.18% from a day low at $0.32 to a day high of $0.45.
The company, currently, has a Zacks Rank #2. The Zacks Consensus Estimate for its current year earnings increased 42% over the past 60 days. The company’s expected earnings growth rate for the current quarter and year are 94.1% and 57.7%, respectively. You can see the complete list of today’s Zacks #1 Rank stocks here.
Dec 31, 2019 registered direct offering of 27,662,518 shares of its common stock at a purchase price of $0.3615 per share, for aggregate gross proceeds of Jan 6, 2017 SNNLive spoke with Ramesh Kumar, President & CEO of Onconova Therapeutics, Inc. (NASDAQ: ONTX) at the LD Micro "Main Event" 2016 in Nov 29, 2019 Onconova Therapeutics, Inc. - ONTX Stock Chart Technical Analysis for 11-29- 2019 Subscribe to My MAIN Channel Here: Onconova Therapeutics, Inc. - ONTX - Stock Price Today - Zacks View Onconova Therapeutics, Inc. ONTX investment & stock information. Get the latest Onconova Therapeutics, Inc. ONTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Should I buy Onconova Therapeutics, Inc. (ONTX) - Zacks Should I buy Onconova Therapeutics, Inc. (ONTX)? Use the Zacks Rank and Style Scores to find out is ONTX is right for your portfolio.
Onconova Therapeutics Inc Stock (ONTX): Technical ...
Nov 06, 2019 · Their average twelve-month price target is $11.43, suggesting that the stock has a possible upside of 3,849.34%. The high price target for ONTX is $25.00 and the low price target for ONTX is $1.30. There are currently 1 hold rating and 2 buy ratings … ONTX - Onconova Therapeutic Stock Price - Barchart.com For US and Canadian Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares.